Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Worries Over Ambiguity & Imprisonment Prompt Australia to Revise Drug Shortages Proposals

Executive Summary

As it presses on with plans to make the reporting of medicines shortages mandatory in Australia, the Therapeutics Goods Administration has taken on board industry’s concerns over how the new scheme will work.

You may also be interested in...



Mandatory Drug Shortage Reporting In Australia Starts In January 2019

Drug sponsors will face penalties in Australia if they fail to comply with new rules on the mandatory reporting of medicines shortages that come into effect at the beginning of 2019 to replace the current "ineffective" voluntary system.

Australian Medicines Shortages Bill Outlines 'Critical Impact' Criteria

Legislation that would introduce the proposed mandatory scheme for reporting medicines shortages has come before the Australian parliament. Among other things it specifies which shortages would have a "critical impact" on patient health.

EMA Probe Finds No Link Between GLP-1s And Suicidal Thoughts & Actions

After reviewing the evidence from non-clinical studies, clinical trials, post-marketing surveillance data and other studies, the European Medicines Agency said there was no need to update the product information for 11 diabetes and weight management drugs.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS123367

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel